국내 제약기업의 연구개발비 및 마케팅 비용이 기업성과에 미치는 영향 연구The Effects of R&D Investment and Marketing Expenses on the Performance of Korean Pharmaceutical Companies
- Other Titles
- The Effects of R&D Investment and Marketing Expenses on the Performance of Korean Pharmaceutical Companies
- Authors
- 정재은; 강민구; 방준석
- Issue Date
- Aug-2019
- Publisher
- 대한약학회
- Keywords
- Pharmaceutical company; R&D investment; marketing expense; company performance; sales growth rate; operating profit
- Citation
- 약 학 회 지, v.63, no.4, pp 204 - 213
- Pages
- 10
- Journal Title
- 약 학 회 지
- Volume
- 63
- Number
- 4
- Start Page
- 204
- End Page
- 213
- URI
- https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/2899
- DOI
- 10.17480/psk.2019.63.4.204
- ISSN
- 0377-9556
- Abstract
- The purpose of this study was to investigate the effect of R&D investment and marketing expenses on theperformance of the Korean pharmaceutical companies. The top-ranked forty companies in Korea were selected and the 6-year-long data were analyzed to obtain the correlations among R&D intensity, marketing expenses, growth rate, operatingprofitability. In addition, the differences between innovative and non-innovative pharmaceutical companies were alsoexamined. Both the amount and the ratio of R&D investment over sales activities were significantly higher in theinnovative pharmaceutical companies compared with the non-innovative pharmaceutical companies. In these competitivecircumstances, R&D investment is indispensable for the sustainable growth in pharmaceutical companies. In conclusion,Korean pharmaceutical companies as well as government bodies should focus on more intensive and strategic R&Dactivities to increase the capabilities for developing innovative new products and future prosperity.
- Files in This Item
-
Go to Link
- Appears in
Collections - 약학대학 > 약학부 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.